Injectable Gel with 0.3% Lidocaine

Size: px
Start display at page:

Download "Injectable Gel with 0.3% Lidocaine"

Transcription

1 Patiet Brochure

2 Table of Cotets Frequetly Asked Questios 4 Safety 6 Troubleshootig 11 Admiistratio 12 Ijectable Gel with.3% Lidocaie Post Marketig Surveillace 13 Post-treatmet Checklist 14 User Assistace Iformatio

3 Frequetly Asked Questios Q What is Perlae -L? A Perlae -L is a crystal clear ijectable gel composed of hyaluroic acid, a atural substace that already exists i the body. Perlae -L is oaimal-based ad free from aimal protei. Allergy pretestig is ot ecessary. Perlae -L cotais.3% lidocaie. The lidocaie i Perlae -L has bee added to reduce the discomfort associated with the treatmet. Q How does Perlae -L work? A Perlae -L is ijected ito the ski with a ultrafie eedle to plump the ski to smooth away wrikles ad folds such as the lies from your ose to the corers of your mouth (asolabial folds) Q How log does Perlae -L last? A Perlae -L effects geerally last about six moths ad gradually disappears from the body. Q Has Perlae -L bee studied? A A cliical study was coducted with Perlae -L to evaluate the pai reducig effect up to 6 miutes after ijectio. This study erolled 6 patiets with moderate to severe asolabial fold wrikles. The study icluded 56 female patiets ad 4 male; 39 were White, 16 were Hispaic or Latio, ad 5 were Africa-America. I this study 95% of patiets experieced less pai after ijectio of Perlae -L tha with Perlae aloe. Please see the below table for additioal iformatio. Timepoit Number of patiets with assessmets Number of patiets with pai reductio No. % After Ijectio Miutes Miutes Miutes Miutes I additio to evaluatig the pai reducig effects, the study assessed patiet satisfactio with Perlae -L treatmet. All 6 subjects were asked to rate the level of improvemet see i their asolabial folds after ijectio with Perlae -L. At day fourtee after ijectio 95.% saw some improvemet (Improved, Much Improved, ad Very Much Improved). See below table for additioal details. Perlae-L Category % Very Much Improved (4) Much Improved (3) Improved (2) No Chage (1) 3 5. Worse (). 4 5

4 Safety Q Who should ot use Perlae -L (Cotraidicatios)? A Safety has ot bee established for use i people who are: Pregat Breast feedig Wishig to be pregat Uder 18 years or over 65 years Highly allergic (for example: gram positive bacteria) Proe to bleedig disorders Q What are some warigs to cosider? A The use of Perlae -L at sites with ski sores, pimples, rashes, hives, cysts, or ifectios should be postpoed util healig is complete. Use of Perlae -L i these istaces could delay healig or make your ski problems worse. You may experiece ski discoloratio (bruisig), swellig, redess, tederess, pai, itchig, or small lumps i the area where you are ijected. If ay of these evets occur, the majority usually last less tha seve days. If ay symptom lasts loger tha two weeks, call the doctor who admiistered the Perlae -L ijectio. Iflammatory papules (red or swolle small bumps) may rarely occur. You may eed atibiotics to treat them. Q What are some potetial risks you may ecouter? A As with all procedures like this, the ijectio of Perlae -L carries a risk of ifectio ad formatio of scar tissue. The safety ad effectiveess of Perlae -L has ot bee established i the treatmet of lips, durig pregacy, i ursig mothers, ad i patiets uder 18 or over 65 years of age. Perlae -L use i ursig could harm you or the ursig child. The use of Perlae -L i Africa-America patiets ca result i hyperpigmetatio (darkeig of ski color), which may take several weeks to correct. If you have previously had facial cold sores, a ijectio ca cause them to come back. The safety of Perlae -L used with other ski therapies such as laser, mechaical or chemical peelig, ad hair removal has ot bee established. The use of Perlae -L with these ski therapies may lead to other side effects such as iflammatio. You should avoid exposig the area(s) treated with Perlae -L to excessive su or UV lamps, ad extreme heat ad cold util ay redess or swellig has disappeared. 6 7

5 Cliical voluteers keepig diaries reported the followig short-lived evets: Perlae -L was evaluated i a cliical study of 6 patiets. The below table shows what patiets reported each day after ijectio of Perlae -L i the diary they kept. The most commo evets were: pai, swellig, redess, tederess, bruisig, itchig ad other. The reportig of these evets decreased over time ad by day 14 most evets had resolved. Duratio of Adverse Evets after Iitial Treatmet, Patiet Diary Bruisig Redess Swellig Pai Tederess Itchig Other Perlae-L Total patiets reportig symptoms 36 (6.%) 34 (56.7%) 42 (7.%) 28 (46.7%) 5 (83.3%) 16 (26.7%) 3 (5.%) 1 6 (16.7%) 9 (26.5%) 4 (9.5%) 17 (6.7%) 6 (12.%) 5 (31.3%) Perlae-L Patiets Number of days (75.%) 24 (7.6%) 33 (78.6%) 11 (39.3%) 4 (8.%) 1 (62.5%) 3 (1.%) (8.3%) 4 (9.5%) 4 (8.%) 1 (6.3%) 14 1 (2.9%) 1 (2.4%) Q What should patiets do prior to treatmet? A Perlae -L requires o pretestig, but you should take a few precautios before beig treated. Avoid usig St. Joh s Wort, high doses of Vitami E supplemets, aspiri, ad other o-steroidal ati-iflammatory medicatios, such as ibuprofe prior to treatmet, because these may icrease bruisig or bleedig at the ijectio site. Also, if you have previously suffered from facial cold sores, discuss this with your physicia. He or she may cosider prescribig a medicatio to miimize recurreces. Q Why add Lidocaie to Perlae? A Lidocaie was added to Perlae to reduce pai ad discomfort durig ad after ijectio. I a cliical study, 6 patiets received Perlae o oe side of the face ad Perlae -L o the other side of the face. Perlae -L had a effect o reducig pai. At the time of ijectio, patiets rated their pai about 47 o a scale of to 1 for the side of the face treated with Perlae. I compariso, patiets rated their pai about 15 o the same scale for the side of the face treated with Perlae -L. Patiets reported less pai o the side of the face treated with Perlae -L up to 6 miutes after treatmet. Q What are the major side effects? A Rarely, the doctor may iadvertetly iject the product ito a blood vessel, which ca cause ijury to the blood supply ad damage to the ski. Rarely, a few people have developed ifectios that must be treated with atibiotics or other treatmet. Ifectio may be hard to treat, but will geerally go away whe the gel is absorbed. 8 9

6 Q Do the ijectios hurt? A Perlae -L is ijected directly ito the ski i tiy amouts by a ultrafie eedle. To help maximize your comfort, you should discuss the use of umbig medicies with your doctor before treatmet. Q How much does Perlae -L treatmet cost? A Perlae -L is a customized procedure based o your specific eeds, so the cost will vary from patiet to patiet. I geeral, the cost of Perlae -L is similar to the cost of similar procedures. Please ask your doctor to give you a estimate of the cost. Troubleshootig Q What should I call my doctor about after the treatmet? A Most side effects like bruisig, swellig, pai, tederess, redess, ad itchig will usually go away withi a week. Call your doctor if you have persistet problems beyod 14 days. Blisters or ski sores that recur may sigal the presece of a herpes ifectio that must be treated. You ca develop a ifectio that should be treated with atibiotics. If you experiece redess, tederess, ad pai that does ot go away you should call your doctor. 1 11

7 Admiistratio Q What is the dose of Perlae -L? A The amout used depeds o your face ad what you would like to have treated. The average patiet who has all of the severe wrikles aroud the mouth corrected will use less tha half a tablespoo. Post Marketig Surveillace: Q: Have there bee adverse evets reported through post market surveillace? A: Serious adverse evets have bee rarely reported. The oly Serious Adverse Evet occurrig i a frequecy of 5 or greater was hypersesitivity (abormal sesitivity). Hypersesitivity reactios occurred withi 1 to 2 days of implatatio ad up to 3 weeks. Reported symptoms icluded swellig, itchig o chest ad back, puffy, burig, watery, ad itchy eyes, ad shortess of breath. Treatmets used icluded steroids, diphehydramie, uspecified itraveous medicatio, oxyge ad various creams. Most hypersesitivity evets have resolved withi 1 to 14 days with or without treatmet. Adverse evets that have occurred at the ijectio sites iclude: discoloratio, bruisig, swellig, lumps/bumps, redess, pai, scarrig, umbess/tiglig, ad ecrosis (death of tissue), ad ischemia (low blood supply due to blockage of a blood vessel). Additioal evets iclude: bacterial ifectios, vasovagal reactios (faitig), herpetic eruptios, broke capillaries (dilated small blood vessels), ad iflammatory reactios (swellig, redess, tederess, hardess ad aceform papules)

8 Is there a post-treatmet checklist to follow after a Perlae -L treatmet? Please observe the followig after treatmet with Perlae -L: Cold compresses (a cloth dipped i cold water, wrug out, ad applied to the ijected area) may be used immediately after treatmet to reduce swellig. Avoid touchig the treated area withi six hours followig treatmet so you do ot accidetally ijure your ski while the area is umb. After that, the area ca be getly washed with soap ad water. Util there is o redess or swellig, avoid exposure of the treated area to itese heat (su lamp or su bathig). If you have previously suffered from facial cold sores, there is a risk that the eedle puctures could cotribute to aother occurrece. Speak to your physicia about medicie to prevet this from happeig agai. Avoid takig aspiri, o-steroidal atiiflammatory medicatios, St. Joh s Wort, ad high doses of Vitami E supplemets for oe week after treatmet. These agets may icrease bruisig ad bleedig at the ijectio site

9 User Assistace Iformatio Your questios about Perlae -L ca be persoally aswered by cotactig the Medicis toll-free call ceter, 24 hours per day, 7 days per week Perlae is a registered trademark of HA North America Sales AB. 21 Medicis Aesthetics Ic Revised 1/21

RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds

RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds A PATIENT S GUIDE RADIESSE Dermal Filler for the Correctio of Moderate to Severe Facial Wrikles ad Folds, Such As Nasolabial Folds Read all the iformatio before you are treated with Radiesse dermal filler.

More information

Table of Contents. Injectable Gel with 0.3% Lidocaine

Table of Contents. Injectable Gel with 0.3% Lidocaine Patient Brochure Table of Contents About Restylane-L 4 Safety 6 Post-Marketing Surveillance 9 About the Procedure 10 Troubleshooting 11 Injectable Gel with 0.3% Lidocaine 2 3 About Restylane-L Q What is

More information

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner.

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner. Restylae Lyft with Lidocaie Ijectable Gel with.% Lidocaie Cautio: Federal Law restricts this device to sale by or o the order of a physicia or licesed practitioer. Descriptio Restylae Lyft with Lidocaie

More information

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner.

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner. Restylae Lyft with Lidocaie Ijectable Gel with.3% Lidocaie Cautio: Federal Law restricts this device to sale by or o the order of a physicia or licesed practitioer. Descriptio Restylae Lyft with Lidocaie

More information

WHAT YOU SHOULD KNOW ABOUT RoACTEMRA

WHAT YOU SHOULD KNOW ABOUT RoACTEMRA RoACTEMRA for Giat Cell Arteritis WHAT YOU SHOULD KNOW ABOUT RoACTEMRA This brochure provides key iformatio to assist i the patiet s uderstadig of the beefits ad risks associated with RoACTEMRA therapy

More information

SCULPTRA Aesthetic (First Treatment Session: N = 116) Cosmoplast (First Treatment Session: N = 117) Severity of Adverse Event a Moderate n.

SCULPTRA Aesthetic (First Treatment Session: N = 116) Cosmoplast (First Treatment Session: N = 117) Severity of Adverse Event a Moderate n. SCULPTRA AESTHETIC Rx Oly (ijectable poly-l-lactic acid) The Sculptra implat package (i.e., lyophilized vials ad syrige) are provided sterile. Cautio: Federal (USA) law restricts this device to sale by

More information

YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2

YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2 YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2 Oly SmartGuard TM from MiiMed takes actio for you whe you eed it most. MiiMed 530G system HIT THE ROAD. WORRY LESS ABOUT GOING LOW. *,1,3 37.5%

More information

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy INFORMATION FOR YOU AND YOUR FAMILY Melody Trascatheter Pulmoary Valve Therapy This booklet is provided to help you ad your loved oes lear more about Melody Trascatheter Pulmoary Valve (TPV) Therapy. Please

More information

Information Following Treatment for Patients with Early Breast Cancer. Bradford Teaching Hospitals. NHS Foundation Trust

Information Following Treatment for Patients with Early Breast Cancer. Bradford Teaching Hospitals. NHS Foundation Trust Iformatio Followig Treatmet for Patiets with Early Breast Cacer Bradford Teachig Hospitals NHS Foudatio Trust What happes ext? You have ow completed your iitial treatmet to remove your breast cacer. There

More information

A PATIENT S GUIDE TO PLASMA EXCHANGE

A PATIENT S GUIDE TO PLASMA EXCHANGE Some drugs may be affected by plasma exchage; ask your doctor about ay impact to drugs you are takig. It is importat to drik water ad cosume foods high i calcium, such as cheese or milk. This ca help your

More information

OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT

OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT Quarterly Report Jue August 2017 Xiyao degrauw Sohomish Health District 3020 Rucker Ave., Everett, WA 98201 Opioid Overdose Related

More information

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment.

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment. Study No.: AVO112760 Title: A Observatioal Study To Assess The Burde Of Illess I Prostate Cacer Patiets With Low To Moderate Risk Of Progressio Ratioale: Little data are available o the burde of illess

More information

There s. more. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *CIDP=Chronic inflammatory demyelinating polyneuropathy.

There s. more. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *CIDP=Chronic inflammatory demyelinating polyneuropathy. There s more to you THAT S WHY THERE S MORE TO GAMUNEX-C YOUR GUIDE TO UNDERSTANDING THE TREATMENT OF CIDP * *CIDP=Chroic iflammatory demyeliatig polyeuropathy. Please see Importat Safety Iformatio o pages

More information

Sexuality and chronic kidney disease

Sexuality and chronic kidney disease Sexuality ad chroic kidey disease T H E K I D N E Y F O U N D A T I O N O F C A N A D A 1 Sexuality ad chroic kidey disease Let s talk about it Sexuality is a vital part of us all. It icludes may aspects

More information

Meningococcal B Prevention Tools for Your Practice

Meningococcal B Prevention Tools for Your Practice Meigococcal B Prevetio Tools for Your Practice NAPNAP MeB Facts for HCPs Fast Facts Although ucommo, MeB is potetially fatal. 1 MeB symptoms progress quickly; death ca occur i 24 hours or less. MeB accouts

More information

A Patient s Guide to Aesthetic Treatments

A Patient s Guide to Aesthetic Treatments A Patient s Guide to Aesthetic Treatments See Important Safety Considerations on Slides 28-30 2009 Medicis Aesthetics Inc. RES 09-106 10/30/10 What happens as we age? Hyaluronic acid (HA) is a naturally

More information

Hospital Measures. Region 1

Hospital Measures. Region 1 Regio 1 Hospital Measures Northwest ad West Cetral: Becker, Beltrami, Clay, Clearwater, Douglas, Grat, Hubbard, Kittso, Lake of the Woods, Mahome, Marshall, Norma, Otter Tail, Peigto, Polk, Pope, Red Lake,

More information

Modified Early Warning Score Effect in the ICU Patient Population

Modified Early Warning Score Effect in the ICU Patient Population Lehigh Valley Health Network LVHN Scholarly Works Patiet Care Services / Nursig Modified Early Warig Score Effect i the ICU Patiet Populatio Ae Rabert RN, DHA, CCRN, NE-BC Lehigh Valley Health Network,

More information

Click to Edit Master Title

Click to Edit Master Title Click to Edit Master Title Persoalized Pai Recovery for City & Couty of Sa Fracisco Employees & Retirees March 9, 2017 Click to Edit Master Title Retirees Police Teachers DPW Desk Fire Fighters PUC MTA

More information

Hospital Measures. Region 3. Twin Cities Metro: Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, Washington

Hospital Measures. Region 3. Twin Cities Metro: Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, Washington Regio 3 Hospital Measures Twi Cities Metro: Aoka, Carver, Dakota, Heepi, Ramsey, Scott, Washigto 48 Hospital Measures November 2010 2010 Health Care Quality Report Hospital Measures Quality of Care for

More information

There s. to them THAT S WHY THERE S MORE TO GAMUNEX-C

There s. to them THAT S WHY THERE S MORE TO GAMUNEX-C There s more to them THAT S WHY THERE S MORE TO GAMUNEX-C YOUR GUIDE TO CARING FOR SOMEONE WITH CIDP* *Chroic iflammatory demyeliatig polyeuropathy. TABLE OF CONTENTS What is CIDP?... 4 What causes CIDP?...

More information

Hospital Measures. Region 2

Hospital Measures. Region 2 Regio 2 Hospital Measures Northeast ad Cetral: Aitki, Beto, Carlto, Cass, Chisago, Cook, Crow Wig, Isati, Itasca, Kaabec, Koochichig, Lake, Mille Lacs, Morriso, Pie, Sherbure, St. Louis, Stears, Todd,

More information

INJECTABLE IMPLANT INSTRUCTIONS FOR USE

INJECTABLE IMPLANT INSTRUCTIONS FOR USE IJECTABLE IMPLAT ISTRUCTIOS FOR USE DEVICE DESCRIPTIO RADIESSE injectable implant is a sterile, non-pyrogenic, semi-solid, cohesive implant, whose principal component is synthetic calcium hydroxylapatite

More information

PATIENT INFORMATION BOOKLET. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms

PATIENT INFORMATION BOOKLET. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms PATIENT INFORMATION BOOKLET Edovascular Stet Grafts: A Treatmet for Abdomial Aortic Aeurysms TABLE OF CONTENTS Itroductio 1 Glossary 2 Abdomial Aorta 4 Abdomial Aortic Aeurysm 5 Causes 6 Symptoms 6 Treatmet

More information

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods The study listed may iclude approved ad o-approved uses, formulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product. Before

More information

A guide to immunisations up to 13 months of age

A guide to immunisations up to 13 months of age A guide to immuisatios up to 13 moths of age The complete routie childhood immuisatio programme These booklets describe the immuisatios offered to your child durig the first 18 years of their life. A guide

More information

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better:

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better: HEALTHPLUS, AN AMERIGROUP COMPANY MakeHealth Happe Vol. 2, 2013 Do I Need Atibiotics? Atibiotics are medicies used to treat bacterial ifectios ad keep them from spreadig. But if a virus makes you sick,

More information

Lidocaine PATIENT INFORMATION GUIDE

Lidocaine PATIENT INFORMATION GUIDE Lidocaine PATIENT INFORMATION GUIDE Table of Contents GLOSSARY............................................. 3 ABOUT RADIESSE (+)................................... 4 SAFETY INFORMATION.................................

More information

DESCRIPTION 1. Composition

DESCRIPTION 1. Composition Shioogi & Co., Ltd. 1 Revised: Jue 2009 (8th versio) Stadard Commodity Classificatio No. of Japa 876133 - Oxacephem atibiotic aget - SHIOMARIN for Itraveous Ijectio 1 g < Latamoxef sodium for ijectio >

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: UM27/189/ The study listed may iclude approved ad o-approved uses, formulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product.

More information

Stacy Norman, D.D.S. William A. Stellenwerf, M.S., D.D.S., P.C Timber Shadows Dr., Bldg. A Kingwood, Texas (281)

Stacy Norman, D.D.S. William A. Stellenwerf, M.S., D.D.S., P.C Timber Shadows Dr., Bldg. A Kingwood, Texas (281) Stac Norma, D.D.S. William A. Stellewerf, M.S., D.D.S., P.C. 2325 Timber Shadows Dr., Bldg. A Kigwood, Texas 77339 (281) 359-9100 PERSONAL HISTORY: Date: Name: Birth Date: Sex: Marital Status: Address:

More information

Hospital Measures. Region 4

Hospital Measures. Region 4 Hospital Measures Regio 4 Regio 4 Southwest, Southeast ad South Cetral, Big Stoe, Blue Earth, Brow, Chippewa, Cottowood, Dodge, Faribault, Fillmore, Freebor, Goodhue, Housto, Jackso, Kadiyohi, Lac qui

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team.

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team. Research Team Early Ambulatio Reduces the Risk of Veous Thromboembolism After Total Kee Replacemet Marily Szekedi, PhD, RN Baafsheh Sadeghi, MD, PhD, School of Medicie, Uiversity of Califoria Davis Patrick

More information

Certify your stroke care program. Tell your community you re ready when needed.

Certify your stroke care program. Tell your community you re ready when needed. Certify your stroke care program. Tell your commuity you re ready whe eeded. Stroke Certificatio Optios STROKE READY PRIMARY STROKE Stroke Ready Certificatio Demostrates to commuity emergecy services ad

More information

PATIENT REGISTRATION

PATIENT REGISTRATION I: First Name: Patiet ls: I f - Resposible First Name: City, State, Zip: Home Phoe: Birth ate: Chart l: eotlcy Holder Resposible Party Party (if someoe other tha the patiet) Work Phoe: Soc. Sec: PATIENT

More information

Preparing for Colon or Rectal Surgery

Preparing for Colon or Rectal Surgery Preparig for Colo or Rectal Surgery A successful surgery starts with plaig OUR MISSION As people of Providece, we reveal God s love for all, especially the poor ad vulerable, through our compassioate service.

More information

New guidance from the Royal College of Radiologists Standards for Intravascular Contrast administration to adult patients 9, 11, 12

New guidance from the Royal College of Radiologists Standards for Intravascular Contrast administration to adult patients 9, 11, 12 Admiistratio of Itraveous (IV) Iodiated Cotrast Media (CM) i the Radiology Departmet Type: Cliical Guidelies Register No: 16031 Status: Public Developed i respose to: Cotributes to CQC Core Stadard umber:

More information

Disclosures. Pain Management in the Optometric Practice. Optometric indications. Optometric indications. Before treatment 4/18/16

Disclosures. Pain Management in the Optometric Practice. Optometric indications. Optometric indications. Before treatment 4/18/16 4/18/16 Disclosures Pai Maagemet i the Optometric Practice Speakers bureau/advisory board: Marc R Bloomestei, OD, FAAO Schwartz Laser Eye Ceter Scottsdale, Arizoa Alco Allerga Akor B&L OCuSOFT Bruder TearLab

More information

Measures of Spread: Standard Deviation

Measures of Spread: Standard Deviation Measures of Spread: Stadard Deviatio So far i our study of umerical measures used to describe data sets, we have focused o the mea ad the media. These measures of ceter tell us the most typical value of

More information

More than skin deep. The medical uses of BOTOX

More than skin deep. The medical uses of BOTOX The medical uses of More tha ski deep Idicatios is a prescriptio medicie that is ijected ito muscles ad used: to treat the abormal head positio ad eck pai that happes with cervical dystoia (CD) i people

More information

prescription drug Approval No. solution Attached dissolving (Content per kit) Flomoxef sodium 1 g (potency) Sodium chloride 50 mg

prescription drug Approval No. solution Attached dissolving (Content per kit) Flomoxef sodium 1 g (potency) Sodium chloride 50 mg Shioogi & Co., Ltd. Revised: Jue 9 (9th versio) Stadard Commodity Classificatio o. of Japa 87 - Oxacephem atibiotic aget - FLUMARI for Itraveous Ijectio. g FLUMARI for Itraveous Ijectio g FLUMARI Kit for

More information

stroke patient handbook

stroke patient handbook OREGON NEUROSCIENCES INSTITUTE Stroke Ceter stroke patiet hadbook To help you ad your family lear about strokes ad stroke care, we have carefully prepared this booklet. It gives you a overview of what

More information

Systemic and Novel Management of Alopecia Areata in Children. Alopecia Areata: Prognosis. Alopecia Areata. Alopecia Areata: Pathogenesis

Systemic and Novel Management of Alopecia Areata in Children. Alopecia Areata: Prognosis. Alopecia Areata. Alopecia Areata: Pathogenesis Systemic ad Novel Maagemet of Alopecia Areata i Childre Kimberly Morel, MD, FAAD, FAAP Associate Professor of Dermatology & Pediatrics S006 - Treatig Severe Ski Disease i Childre 02/16/2018, 9:00 AM Room

More information

MEDICAL HOME: Inside: Feeling Blue about the Holidays? Disordered Eating

MEDICAL HOME: Inside: Feeling Blue about the Holidays? Disordered Eating Tee Health Quarter 4, 2011 www.myamerigroup.com/tn MEDICAL HOME: Your First Stop for Health Care Do you have a medical home? It s the first place you should go whe you are sick or hurt. Your medical home

More information

STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER

STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER March 3. Vol., No. ISSN 37-3 IJRSS & K.A.J. All rights reserved STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER Dr. Mohammad M. Faqe Hussai (), Asst. Lecturer

More information

Raising Healthy Kids: Colostrum Management and Prevention of Failure of Passive Transfer

Raising Healthy Kids: Colostrum Management and Prevention of Failure of Passive Transfer 11/11/14! Raisig Healthy Kids: Colostrum Maagemet ad Prevetio of Failure of Passive Trasfer Cassi Plummer, DVM Iowa State Uiversity College of Veteriary Medicie Itroductio Colostrum Maagemet Failure of

More information

Basic Requirements. of meeting cow herd production and profitability goals for the beef cattle enterprise.

Basic Requirements. of meeting cow herd production and profitability goals for the beef cattle enterprise. Basic Requiremets It is imperative that cattle producers have a adequate uderstadig of the basic utriet requiremets of the cow herd to make iformed ad effective utritio-related decisios. by Matt Hersom,

More information

Hypertension in patients with diabetes is a well recognized

Hypertension in patients with diabetes is a well recognized Cotrol of Hypertesio amog Type II Diabetics Kawther El-Shafie, Sayed Rizvi Abstract Objectives: Numerous studies have cofirmed the high prevalece of hypertesio amog type 2 diabetics, ad that itesive hypertesive

More information

Intrathecal pumps for pain therapy. Lennart Stieglitz

Intrathecal pumps for pain therapy. Lennart Stieglitz Itrathecal pumps for pai therapy Leart Stieglitz Itrathecal pumps itrathecal? History Morphi Baclofe Evaluatio Implatatio Complicatios Itrathekale Schmerztherapie Pai is perfect miserie, the worst of evils,

More information

Sample. Do not reproduce.

Sample. Do not reproduce. The HealthyLife Maage Your Pai Self-Care Guide helps you idetify ad describe differet types of pai. It presets twety-five methods to treat pai. It also helps you decide whe to maage pai o your ow ad whe

More information

Management of Preschool Recurrent Wheezing and Asthma: A Phenotype-Based Approach

Management of Preschool Recurrent Wheezing and Asthma: A Phenotype-Based Approach Maagemet of Preschool Recurret Wheezig ad Asthma: A Pheotype-Based Approach Leoard B. Bacharier, MD Robert C. Struk Edowed Chair for Lug ad Respiratory Research Professor of Pediatrics & Medicie Cliical

More information

Opinion 22 January 2014

Opinion 22 January 2014 The legally bidig text is the origial Frech versio TRANSPARENCY COMMITTEE Opiio 22 Jauary 214 VELCADE 1 mg, powder for solutio for ijectio B/1 vial (CIP: 349 386 657 9 6) VELCADE 3.5 mg, powder for solutio

More information

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES*

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES* FERTILITY AND STERILITY Copyright 1972 by The Williams & Wilkis Co. Vol. 23, No.4, April 1972 Prited i U.S.A. DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES* R. ELIASSON,

More information

Report on sexual activity and contraceptive methods for female. June 2014

Report on sexual activity and contraceptive methods for female. June 2014 Report o sexual activity ad cotraceptive methods for female Jue 2014 Date: 16 th Jue 2014 Table of cotet A. Research backgroud B. Research desig C. Respodet profile D. Key fidigs E. Detail fidigs 1. Frequetly

More information

APPROVAL REQUIRED. By approving this proof you are confirming that the contact information is correct.

APPROVAL REQUIRED. By approving this proof you are confirming that the contact information is correct. APPROVAL REQUIRED Attached is a proof for your review. Please pay particular attetio to cotact iformatio such as phoe umbers, email addresses, web addresses ad mailig address. By approvig this proof you

More information

SPONDYLODISCITIS KEY POINTS

SPONDYLODISCITIS KEY POINTS KEY POINTS SEPPO KOSKINEN, M.D., Ph.D. Professor Divisio of Radiology Departmet of Cliical Sciece, Itervetio ad Techology (CLINTEC) Seior Cosultat Fuctio Imagig & Physiology Fuctioal Area for Trauma ad

More information

MICHELANGELO: OASIS 5 Women s Substudy

MICHELANGELO: OASIS 5 Women s Substudy MICHELANGELO: OASIS 5 Wome s Substudy Dr. Eva Swah Departmet of Cardiology, Heart Cetre, Uiversity Hospital, Liköpig Swede Disclosure Fuded by Saofi-Sythelabo, Orgao NV ad GSK Dr. Swah has o coflicts of

More information

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients 22 4th Iteratioal Coferece o Bioiformatics ad Biomedical Techology IPCBEE vol.29 (22) (22) IACSIT Press, Sigapore Platar Pressure Differece: Decisio Criteria of Motor Relearig Feedback Isole for Hemiplegic

More information

Mechanism of Action: The Importance of Liver THR-β in NASH

Mechanism of Action: The Importance of Liver THR-β in NASH MGL-3196, a selective thyroid hormoe receptor-beta agoist, sigificatly decreases hepatic fat i NASH patiets at 12 weeks, the primary edpoit i a 36 week serial liver biopsy study Stephe Harriso 1, Sam Moussa

More information

A COMBINATION OF ANALGESIC AND IN POSTOPERATIVE PAIN

A COMBINATION OF ANALGESIC AND IN POSTOPERATIVE PAIN Brit. J. Aaesth. (1960), 32, 481 A COMBINATION OF ANALGESIC AND IN OSTOERATIVE AIN BY ANTAGONIST G. HOSSLI AND G. BERGMANN The Departmet of Aaesthesia, Umversitdtskliik, Zurich, Switzerlad Cliicias ofte

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud Uiversity Nijmege The followig full text is a publisher's versio. For additioal iformatio about this publicatio click this lik. http://hdl.hadle.et/066/5655

More information

Statistics 11 Lecture 18 Sampling Distributions (Chapter 6-2, 6-3) 1. Definitions again

Statistics 11 Lecture 18 Sampling Distributions (Chapter 6-2, 6-3) 1. Definitions again Statistics Lecture 8 Samplig Distributios (Chapter 6-, 6-3). Defiitios agai Review the defiitios of POPULATION, SAMPLE, PARAMETER ad STATISTIC. STATISTICAL INFERENCE: a situatio where the populatio parameters

More information

COMPARISON OF A NEW MICROCRYSTALLINE

COMPARISON OF A NEW MICROCRYSTALLINE Br. J. cli. Pharmac. (1979), 8, 59-64 COMPARISON OF A NEW MICROCRYSTALLINE DICOUMAROL PREPARATION WITH WARFARIN UNDER ROUTINETREATMENTCONDITIO D. LOCKNER & C. PAUL Departmet of Medicie, Thrombosis Uit,

More information

5/7/2014. Standard Error. The Sampling Distribution of the Sample Mean. Example: How Much Do Mean Sales Vary From Week to Week?

5/7/2014. Standard Error. The Sampling Distribution of the Sample Mean. Example: How Much Do Mean Sales Vary From Week to Week? Samplig Distributio Meas Lear. To aalyze how likely it is that sample results will be close to populatio values How probability provides the basis for makig statistical ifereces The Samplig Distributio

More information

Quick Reference to Transthoracic Echo Screening

Quick Reference to Transthoracic Echo Screening Quick Referece to Trasthoracic Echo Screeig Idicatio: The MitraClip Clip Delivery System is idicated for the percutaeous reductio of sigificat symptomatic mitral regurgitatio (MR 3+) due to primary abormality

More information

Esteemed Faculty. Michael A. LeNoir MD, FAAP, FAAAI. Jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Not One More Life, Inc.

Esteemed Faculty. Michael A. LeNoir MD, FAAP, FAAAI. Jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Not One More Life, Inc. Esteemed Faculty Michael A. LeNoir MD, FAAP, FAAAI Joitly sposored by AKH Ic., Advacig Kowledge i Healthcare ad Not Oe More Life, Ic. otoemorelife.org Allergy ad Asthma I Childre 70% o the post-test. A

More information

Objectives. Sampling Distributions. Overview. Learning Objectives. Statistical Inference. Distribution of Sample Mean. Central Limit Theorem

Objectives. Sampling Distributions. Overview. Learning Objectives. Statistical Inference. Distribution of Sample Mean. Central Limit Theorem Objectives Samplig Distributios Cetral Limit Theorem Ivestigate the variability i sample statistics from sample to sample Fid measures of cetral tedecy for distributio of sample statistics Fid measures

More information

Clinical Research The details of the studies undertaken year wise along with the outcomes is given below: SNo Name of Project

Clinical Research The details of the studies undertaken year wise along with the outcomes is given below: SNo Name of Project No. studies take Cliical Research 2012-13 No. publi 9 4 The details the studies take year wise alog with the outcomes is give below: 1. Homoeopathic therapy for lower uriary tract symptoms i me with Beig

More information

Pilot and Exploratory Project Support Grant

Pilot and Exploratory Project Support Grant KEY DATES LETTERS OF INTENT DUE November 3, 2014 5:00 pm est FULL PROPOSAL INVITATIONS November 17, 2014 FULL PROPOSAL DEADLINE Jauary 15, 2015 5:00 pm est NOTIFICATION OF AWARDS April, 2015 Pilot ad Exploratory

More information

Years K-2. Information. Introduction. Key understandings

Years K-2. Information. Introduction. Key understandings Iformatio Updated Jue 2016 Itroductio These activities provide the kowledge ad uderstadig ad embedded skill developmet that foster allergy awareess ad safety amog Foudatio-Year 2 studets. These uderstadigs

More information

The Skeletal System: Bone Tissue Chapter 6. Copyright 2009, John Wiley & Sons, Inc.

The Skeletal System: Bone Tissue Chapter 6. Copyright 2009, John Wiley & Sons, Inc. The Skeletal System: Boe Tissue Chapter 6 Fuctios of Boe ad Skeletal System Support Protectio Assistace i Movemet Mieral Homeostasis Blood Cell Productio(Hemopoiesis) q Triglyceride Storage q Yellow boe

More information

WHAT YOU NEED TO KNOW ABOUT CANCER

WHAT YOU NEED TO KNOW ABOUT CANCER REPUBLIC OF KENYA MINISTRY OF HEALTH WHAT YOU NEED TO KNOW ABOUT CANCER A GUIDE FOR PATIENTS AND CAREGIVERS KENCO Keya Network of Cacer Orgaisatios ACKNOWLEDGEMENT This booklet was prepared by the Keya

More information

VAPREVENT SYSTEM. Evidence-based innovation in oral care

VAPREVENT SYSTEM. Evidence-based innovation in oral care VAPREVENT SYSTEM Evidece-based iovatio i oral care V A P Vetilator Associated Peumoia (VAP) is the secod most commo hospital-acquired ifectio. 1 It is deadlier tha either cetral lie-associated bloodstream

More information

n Need for surgery recently challenged n increasing adult literature n emerging pediatric evidence n Parents may want to avoid operation

n Need for surgery recently challenged n increasing adult literature n emerging pediatric evidence n Parents may want to avoid operation ANTIBIOTICS VS APPENDECTOMY FOR NON- PERFORATED APPENDICITIS Shaw D. St. Peter, M.D. The APPY trial Multiceter radomized cotrolled trial comparig appedectomy versus o-operative treatmet for acute o-perforated

More information

Disclosure. Update in Pediatric Asthma 7/5/16. Topics. California Society for Respiratory Care Indian Wells, CA June 7, 2016

Disclosure. Update in Pediatric Asthma 7/5/16. Topics. California Society for Respiratory Care Indian Wells, CA June 7, 2016 Update i Pediatric Asthma Califoria Society for Respiratory Care Idia Wells, CA Jue 7, 2016 Sade Okelo, MD, PhD The David Geffe School of Medicie at UCLA Mattel Childre s Hospital Divisio of Pediatric

More information

Safety concerns regarding inhaled adrenergic. Long-acting b-agonists: a review of formoterol safety data from asthma clinical trials

Safety concerns regarding inhaled adrenergic. Long-acting b-agonists: a review of formoterol safety data from asthma clinical trials Eur Respir J 2009; 33: 21 32 DOI: 10.1183/09031936.00145006 CopyrightßERS Jourals Ltd 2009 Log-actig b-agoists: a review of formoterol safety data from asthma cliical trials M.R. Sears*,#, A. Ottosso ",

More information

HELP RESTORE A MORE YOUTHFUL LOOK

HELP RESTORE A MORE YOUTHFUL LOOK HELP RESTORE A MORE YOUTHFUL LOOK Get the lift you want with RADIESSE and smooth those etched-in lines and wrinkles with BELOTERO BALANCE What are RADIESSE and BELOTERO BALANCE? RADIESSE and BELOTERO BALANCE

More information

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager M e sotheliom a a UK ursig ad iform atio project Mavis Robiso Project Maager Mesotheliom a Mesothelioma is a cacer. It most commoly affects the outer liig of the lugs (the pleura). I over 70% of cases

More information

One-week Oral Challenge with Penicillin in Diagnosis of Penicillin Allergy

One-week Oral Challenge with Penicillin in Diagnosis of Penicillin Allergy Acta Derm Veereol 2012; 92: 307 312 INVESTIGATIVE REPORT Oe-week Oral Challege with Peicilli i Diagosis of Peicilli Allergy Jai Hjortlud, Charlotte Gotthard Mortz, Per Stahl Skov, Esbe Eller, Joha Millig

More information

INTERNATIONAL STUDENT TIMETABLE SYDNEY CAMPUS

INTERNATIONAL STUDENT TIMETABLE SYDNEY CAMPUS INTERNATIONAL STUDENT TIMETABLE KEY TERM DATES Term Iductio Day Term Dates Public Holidays Studet Fees 2013/14 Holiday Periods* Commece Util* Commece Util ALL studets 1, 2014 Fri 24 Ja Fri 24 Ja Su 6 Apr

More information

CURRENT ALCOHOL USE IS ASSOCIATED WITH A REDUCED RISK OF HOT FLASHES IN MIDLIFE WOMEN

CURRENT ALCOHOL USE IS ASSOCIATED WITH A REDUCED RISK OF HOT FLASHES IN MIDLIFE WOMEN Alcohol & Alcoholism Vol. 40, No. 6, pp. 563 568, 2005 Advace Access publicatio 8 August 2005 doi:10.1093/alcalc/agh191 CURRENT ALCOHOL USE IS ASSOCIATED WITH A REDUCED RISK OF HOT FLASHES IN MIDLIFE WOMEN

More information

Chapter 25 Fluid, electrolyte, and acid-base homeostasis

Chapter 25 Fluid, electrolyte, and acid-base homeostasis Chapter 25 Fluid, electrolyte, ad acid-base homeostasis Body Fluid Compartmets I lea adults, body fluids costitute 55% of female ad 60% of male total body mass Itracellular fluid (ICF) iside cells About

More information

1.#GLOSSARY#.#2 2.#PRODUCT#DESCRIPTION# #ABOUT#BELLAFILL #.#4 3.#INDICATION/INTENDED#USE#.#4 4.#SAFETY#.#4 5.#RISKS#.#6 6.#7 7.#ABOUT#THE#PROCEDURE#

1.#GLOSSARY#.#2 2.#PRODUCT#DESCRIPTION# #ABOUT#BELLAFILL #.#4 3.#INDICATION/INTENDED#USE#.#4 4.#SAFETY#.#4 5.#RISKS#.#6 6.#7 7.#ABOUT#THE#PROCEDURE# ! Table&of&Contents& 1.#GLOSSARY#...#2! 2.#PRODUCT#DESCRIPTION# #ABOUT#BELLAFILL #...#4! 3.#INDICATION/INTENDED#USE#...#4! 4.#SAFETY#...#4! 5.#RISKS#...#6! 6.#POST#MARKETING#SURVELLIANCE#...#7! 7.#ABOUT#THE#PROCEDURE#...#8!

More information

Skeletal System. Bones Protect. Bones. Bones Store. Bones Move SECTION 2: THE SKELETAL SYSTEM 4/4/16

Skeletal System. Bones Protect. Bones. Bones Store. Bones Move SECTION 2: THE SKELETAL SYSTEM 4/4/16 Skeletal System Skeletal system: the orga system whose primary fuctio is to support ad protect the body ad to allow the body to move SECTION 2: THE SKELETAL SYSTEM Boes The adult huma skeleto has 206 boes.

More information

How a Written Back-Up Plan Saves Money and Lives. Jill Emerick, MD

How a Written Back-Up Plan Saves Money and Lives. Jill Emerick, MD DKA, Quality, ad Costs: How a Writte Back-Up Pla Saves Moey ad Lives Traci Carter, MA, RN, CDE Aa Isfort, MD Kare Vogt, MD Jill Emerick, MD 18 // AADE I Practice // March 2017 Early last summer, we, the

More information

Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus

Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus Cliical evidece of the role of belimumab i the treatmet of systemic lupus erythematosus Cli. Ivest. (2011) 1(11), 1555 1561 Belimumab is a huma moocloal atibody that bids soluble B lymphocyte stimulator,

More information

Retention in HIV care among a commercially insured population,

Retention in HIV care among a commercially insured population, Retetio i HIV care amog a commercially isured populatio, 2006-2012 Kathy Byrd, MD, MPH 10th Iteratioal Coferece o HIV Treatmet ad Prevetio Adherece Jue 28 30, 2015 Natioal Ceter for HIV/AIDS, Viral Hepatitis,

More information

Teacher Manual Module 3: Let s eat healthy

Teacher Manual Module 3: Let s eat healthy Teacher Maual Module 3: Let s eat healthy Teacher Name: Welcome to FLASH (Fu Learig Activities for Studet Health) Module 3. I the Uited States, more studets are developig type 2 diabetes tha ever before.

More information

Patient Enrollment Form

Patient Enrollment Form Patiet Erollmet Form 1 HEALTHCARE PROFESSIONAL (HCP) HCP Name Facility Name Address 2489 W. BUSINESS 77 City SAN BENITO State TXZip 78586 Tel ( 956 ) 412-2700 Fax ( 956 ) 361-4742 HCP Email KATHLEEN SALVATORE

More information

Review for Chapter 9

Review for Chapter 9 Review for Chapter 9 1. For which of the followig ca you use a ormal approximatio? a) = 100, p =.02 b) = 60, p =.4 c) = 20, p =.6 d) = 15, p = 2/3 e) = 10, p =.7 2. What is the probability of a sample

More information

Psychophysiological Alterations in Posttraumatic Stress Disorder

Psychophysiological Alterations in Posttraumatic Stress Disorder Psychophysiological Alteratios i Posttraumatic Stress Disorder Developmet Over Time ad Respose to Treatmet Michael G. Griffi, Ph.D. This work was supported by NIMH grats MH55688 (Griffi) ad MH55542 (Resick)

More information

You Take My Breath Away: Management of Asthma in Children. David Seal, Pharm.D., BCACP, MS March 10, 2019

You Take My Breath Away: Management of Asthma in Children. David Seal, Pharm.D., BCACP, MS March 10, 2019 You Take My Breath Away: Maagemet of Asthma i Childre David Seal, Pharm.D., BCACP, MS March 10, 2019 Disclosures I have othig to disclose. Use of the GINA slide set has bee authorized. Pediatric Asthma

More information

Valve Aortic Accessories Trifecta Valve Sizer Set Handles Global Headquarters Cardiovascular Division St. Jude Medical Coordination Center BVBA

Valve Aortic Accessories Trifecta Valve Sizer Set Handles Global Headquarters Cardiovascular Division St. Jude Medical Coordination Center BVBA Trifecta Valve Whe the Goal Is Superior Hemodyamics 1 The Valve Is Trifecta. Itroducig the ext-geeratio pericardial tissue heart valve ad perfect complemet to the lie of tissue valves from St. Jude Medical

More information

Chronic / Sublethal Bioassays

Chronic / Sublethal Bioassays Chroic / Sublethal Bioassays Tab N Dr. Todd S. Bridges KEY WORDS: Chroic Sublethal Toxicity, Neathes, Leptocheirus, Hyalella, Chiroomus Why Chroic Sublethal Toxicity Tests? Required by Federal regulatios

More information

Estimation and Confidence Intervals

Estimation and Confidence Intervals Estimatio ad Cofidece Itervals Chapter 9 McGraw-Hill/Irwi Copyright 2010 by The McGraw-Hill Compaies, Ic. All rights reserved. GOALS 1. Defie a poit estimate. 2. Defie level of cofidece. 3. Costruct a

More information

Working Together to Improve Patient Safety...Innovations in Fall Prevention. My Hope: My Goals. Challenges

Working Together to Improve Patient Safety...Innovations in Fall Prevention. My Hope: My Goals. Challenges Workig Together to Improve Patiet Safety...Iovatios i Fall Prevetio Pat Quigley, PhD, MPH, ARNP, CRRN, FAAN, FAAN Nurse Cosultat Former Associate Director, VISN 8 Patiet Safety Ceter Former Associate Chief

More information

Specialties. SFunctional Acids

Specialties. SFunctional Acids Specialties SFuctioal Acids Fuctioal Acids Fuctioal modificatio advaced tools Jugbuzlauer s experiece has led to a outstadig rage of products to satisfy customer eeds for sophisticated fuctioal igrediets

More information

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University.

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University. The Natioal Audit Office udertook a self-assessmet cesus of Commuity Metal Health Teams for Older People (CMHTs) betwee September ad December 2006. The overall fidigs are preseted i the Natioal Audit Office

More information

Simple intervention to improve detection of hepatitis B and hepatitis C in general practice

Simple intervention to improve detection of hepatitis B and hepatitis C in general practice Simple itervetio to improve detectio of hepatitis B ad hepatitis C i geeral practice Zayab al-lami (GP-Birmigham) Co-authors:-Sarah Powell, Sally Bradshaw, Amada Lambert, David Mutimer ad Adrew Rouse Presetatio

More information